Registry study for neuroendocrine tumors in patients worldwide
Part of Cancer clinical trials.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neuroendocrine tumor (in the gut/pancreas or the lungs/airways) or a neuroendocrine carcinoma in those areas
- Your situation can be before or after surgery
- You may be in a “watch and wait” plan (no active treatment) or receiving treatment
- Your treatment may include certain medicines like somatostatin analogs, PRRT, or other targeted therapies
- You are able and willing to sign an informed consent form to join the registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether specific blood “biomarkers” can help confirm a type of cancer called NEN (neuroendocrine neoplasm) and show whether treatment is working early. It may help doctors start or adjust treatment sooner, especially for cancers that are advanced or have spread.
This study examines how doctors treat gastroenteropancreatic neuroendocrine tumors (rare slow-growing cancers of the stomach, pancreas, or intestines) and how patients respond. Researchers will review medical records from 2018–2025 to understand which treatments work best and help improve care for future patients.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This is a registry study that collects medical information from adults with neuroendocrine tumors (NETs) that start in the digestive organs. It helps researchers understand these cancers better and may support future studies.
This study is tracking patients with advanced neuroendocrine tumors to see which treatments help them live longer without severe side effects, and how these side effects affect daily life. It aims to find the best treatment approaches for people like you.
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
Hear when a new Carcinoid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.